MedPath

Hangzhou Yuyuan Bioscience Technology Co., Ltd.

🇨🇳China
Ownership
Private
Established
2019-06-06
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (100.0%)

Randomized Controlled Study of Comparing Follitrope Versus Gonal-f in Chinese Infertility Women.

Phase 3
Completed
Conditions
Infertility, Female
First Posted Date
2018-04-24
Last Posted Date
2018-04-24
Lead Sponsor
Hangzhou YuYuan Bioscience Technology Co., Ltd.
Target Recruit Count
451
Registration Number
NCT03506243
Locations
🇨🇳

Hangzhou Yuyuan Bioscience Technology Co.,Ltd, Hangzhou, Zhejiang, China

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.